Literature DB >> 10528852

A molecular investigation of true dominance in Huntington's disease.

Y Narain1, A Wyttenbach, J Rankin, R A Furlong, D C Rubinsztein.   

Abstract

Huntington's disease (HD) is thought to show true dominance, since subjects with two mutant alleles have been reported to have similar ages at onset of disease compared to heterozygous sibs. We have investigated this phenomenon using a cell culture model. Protein aggregate formation was used as an indicator for pathology, as intraneuronal huntingtin inclusions are associated with pathology in vitro and in vivo. We showed that cytoplasmic and nuclear aggregates are formed by constructs comprising part of exon 1 of huntingtin with 41, 51, 66, or 72 CAG repeats, in a rate that correlates with repeat number. No inclusions were seen with 21 CAG repeat constructs. Mutant and wild type huntingtin fragments can be sequestered into inclusions seeded by a mutant huntingtin. Wild type huntingtin did not enhance or interfere with protein aggregation. The rate of protein aggregation was dose dependent for all mutant constructs tested. These experiments suggested a model for the dominance observed in HD; the decrease in the age at onset of a mutant homozygote may be small compared to the variance in the age at onset for that specific repeat number in heterozygotes. Our experiments also provide a model, which may explain the different repeat size ranges seen in patients and healthy controls for the different polyglutamine diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10528852      PMCID: PMC1734229          DOI: 10.1136/jmg.36.10.739

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  39 in total

1.  In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease.

Authors:  A S Hackam; R Singaraja; T Zhang; L Gan; M R Hayden
Journal:  Hum Mol Genet       Date:  1999-01       Impact factor: 6.150

Review 2.  Protein fate in neurodegenerative proteinopathies: polyglutamine diseases join the (mis)fold.

Authors:  H L Paulson
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

3.  Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture.

Authors:  J K Cooper; G Schilling; M F Peters; W J Herring; A H Sharp; Z Kaminsky; J Masone; F A Khan; M Delanoy; D R Borchelt; V L Dawson; T M Dawson; C A Ross
Journal:  Hum Mol Genet       Date:  1998-05       Impact factor: 6.150

4.  Functional analysis of the Huntington's disease (HD) gene promoter.

Authors:  R Coles; R Caswell; D C Rubinsztein
Journal:  Hum Mol Genet       Date:  1998-05       Impact factor: 6.150

5.  A cellular model that recapitulates major pathogenic steps of Huntington's disease.

Authors:  A Lunkes; J L Mandel
Journal:  Hum Mol Genet       Date:  1998-09       Impact factor: 6.150

6.  Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice.

Authors:  I A Klement; P J Skinner; M D Kaytor; H Yi; S M Hersch; H B Clark; H Y Zoghbi; H T Orr
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

7.  Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA.

Authors:  P H Reddy; M Williams; V Charles; L Garrett; L Pike-Buchanan; W O Whetsell; G Miller; D A Tagle
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

8.  Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

Authors:  F Saudou; S Finkbeiner; D Devys; M E Greenberg
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

9.  Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila.

Authors:  J M Warrick; H L Paulson; G L Gray-Board; Q T Bui; K H Fischbeck; R N Pittman; N M Bonini
Journal:  Cell       Date:  1998-06-12       Impact factor: 41.582

10.  Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation.

Authors:  M K Perez; H L Paulson; S J Pendse; S J Saionz; N M Bonini; R N Pittman
Journal:  J Cell Biol       Date:  1998-12-14       Impact factor: 10.539

View more
  66 in total

Review 1.  Huntington's disease: the coming of age.

Authors:  Mritunjay Pandey; Usha Rajamma
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

2.  An aggregation sensing reporter identifies leflunomide and teriflunomide as polyglutamine aggregate inhibitors.

Authors:  Rodrigo A Fuentealba; Jayne Marasa; Marc I Diamond; David Piwnica-Worms; Conrad C Weihl
Journal:  Hum Mol Genet       Date:  2011-11-03       Impact factor: 6.150

3.  The first year.

Authors:  Johannes Attems
Journal:  Acta Neuropathol       Date:  2019-12-12       Impact factor: 17.088

4.  Hydrophilic protein associated with desiccation tolerance exhibits broad protein stabilization function.

Authors:  Sohini Chakrabortee; Chiara Boschetti; Laura J Walton; Sovan Sarkar; David C Rubinsztein; Alan Tunnacliffe
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-02       Impact factor: 11.205

5.  Deletion of the huntingtin polyglutamine stretch enhances neuronal autophagy and longevity in mice.

Authors:  Shuqiu Zheng; Erin B D Clabough; Sovan Sarkar; Marie Futter; David C Rubinsztein; Scott O Zeitlin
Journal:  PLoS Genet       Date:  2010-02-05       Impact factor: 5.917

6.  Laforin, the most common protein mutated in Lafora disease, regulates autophagy.

Authors:  Carmen Aguado; Sovan Sarkar; Viktor I Korolchuk; Olga Criado; Santiago Vernia; Patricia Boya; Pascual Sanz; Santiago Rodríguez de Córdoba; Erwin Knecht; David C Rubinsztein
Journal:  Hum Mol Genet       Date:  2010-05-07       Impact factor: 6.150

7.  Puromycin-sensitive aminopeptidase protects against aggregation-prone proteins via autophagy.

Authors:  Fiona M Menzies; Raphael Hourez; Sara Imarisio; Marcel Raspe; Oana Sadiq; Dhia Chandraratna; Cahir O'Kane; Kenneth L Rock; Eric Reits; Alfred L Goldberg; David C Rubinsztein
Journal:  Hum Mol Genet       Date:  2010-09-09       Impact factor: 6.150

8.  Inactivation of Drosophila Huntingtin affects long-term adult functioning and the pathogenesis of a Huntington's disease model.

Authors:  Sheng Zhang; Mel B Feany; Sudipta Saraswati; J Troy Littleton; Norbert Perrimon
Journal:  Dis Model Mech       Date:  2009-04-06       Impact factor: 5.758

9.  Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro.

Authors:  Eugenia Trushina; Roy B Dyer; John D Badger; Daren Ure; Lars Eide; David D Tran; Brent T Vrieze; Valerie Legendre-Guillemin; Peter S McPherson; Bhaskar S Mandavilli; Bennett Van Houten; Scott Zeitlin; Mark McNiven; Ruedi Aebersold; Michael Hayden; Joseph E Parisi; Erling Seeberg; Ioannis Dragatsis; Kelly Doyle; Anna Bender; Celin Chacko; Cynthia T McMurray
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

10.  Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3.

Authors:  Fiona M Menzies; Jeannette Huebener; Maurizio Renna; Michael Bonin; Olaf Riess; David C Rubinsztein
Journal:  Brain       Date:  2009-12-09       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.